Scholarlink

<p>Since the emergence of the COVID-19 pandemic, the successful distribution and application of mRNA vaccines have helped to contain the spread of SARS-CoV-2 and saved countless lives worldwide. mRNA vaccines are not only being developed and tested for infectious diseases, but also for numerous new applications, such as cancer therapy. Although the general mechanisms of mRNA vaccinations have been thoroughly studied, data regarding the local anatomical distribution after vaccination have been scarce. Here, we investigated the spatiotemporal distribution of BNT162b2 and mRNA-1273 vaccines in mice and deceased humans. We found that vaccine-related mRNA and spike protein could be detected at the vaccination site of patients and mice, with muscle-associated fibroblasts being a major source of spike protein expression. In contrast, we did not detect expression of vaccine-related spike protein in immune cells at the injection site. While mRNA-vaccine-related mRNA or spike protein could not be detected in extramuscular organs in humans in our study, it was detected in several organs in mice, even up to 7 days after initial vaccination. Together, these data enhance our understanding of mRNA vaccine kinetics and distribution patterns, providing valuable insights to guide scientists in refining future mRNA vaccine-based therapies whenever appropriate.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月19日

查看全文
  • Fabian Heinrich,
  • Jöran Lücke,
  • Siwen Zhang,
  • Morsal Sabihi,
  • Christian Bernreuther,
  • Katja Giersch,
  • Lena Allweiss,
  • Kristin Hartmann,
  • Edda Thies,
  • Philine Lange,
  • Jakob Matschke,
  • Anja A. Kühl,
  • Ronja Mothes,
  • Helena Radbruch,
  • Ann Sophie Schröder,
  • Axel Heinemann,
  • Maura Dandri,
  • Martin Aepfelbacher,
  • Samuel Huber,
  • Anastasios Giannou,
  • Markus Glatzel,
  • Benjamin Ondruschka,
  • Marc Lütgehetmann,
  • Susanne Krasemann

摘要

Since the emergence of the COVID-19 pandemic, the successful distribution and application of mRNA vaccines have helped to contain the spread of SARS-CoV-2 and saved countless lives worldwide. mRNA vaccines are not only being developed and tested for infectious diseases, but also for numerous new applications, such as cancer therapy. Although the general mechanisms of mRNA vaccinations have been thoroughly studied, data regarding the local anatomical distribution after vaccination have been scarce. Here, we investigated the spatiotemporal distribution of BNT162b2 and mRNA-1273 vaccines in mice and deceased humans. We found that vaccine-related mRNA and spike protein could be detected at the vaccination site of patients and mice, with muscle-associated fibroblasts being a major source of spike protein expression. In contrast, we did not detect expression of vaccine-related spike protein in immune cells at the injection site. While mRNA-vaccine-related mRNA or spike protein could not be detected in extramuscular organs in humans in our study, it was detected in several organs in mice, even up to 7 days after initial vaccination. Together, these data enhance our understanding of mRNA vaccine kinetics and distribution patterns, providing valuable insights to guide scientists in refining future mRNA vaccine-based therapies whenever appropriate.